Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT00602667
Title Risk-Adapted Therapy for Young Children With Embryonal Brain Tumors, Choroid Plexus Carcinoma, High Grade Glioma or Ependymoma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors St. Jude Children's Research Hospital
Indications

ependymoblastoma

brain glioma

childhood medulloblastoma

gliosarcoma

pineoblastoma

neuroblastoma

atypical teratoid rhabdoid tumor

medulloblastoma

supratentorial primitive neuroectodermal tumor

Therapies

Cisplatin + Cyclophosphamide + Methotrexate + Vincristine Sulfate

Cyclophosphamide + Etoposide + Topotecan

Cyclophosphamide + Erlotinib + Topotecan

Age Groups: child
Covered Countries USA


No variant requirements are available.